Estimation of hub genes and exploration of multi-omics level alterations in the landscape of lung adenocarcinoma

被引:0
作者
Li, Guangyao [1 ]
Atiq, Warda [2 ]
Hashmi, Muhammad Furqan [3 ]
Ibrahim, Shebl Salah [4 ]
Abdulsalam, Kholoud Abdulrhman Al [5 ]
Kadham, Mustafa Jawad [6 ]
Al-Azzawi, Abdul Kareem J. [7 ]
Aufy, Mohammed [8 ]
Abdel-Maksoud, Mostafa A. [9 ,10 ]
机构
[1] Second Peoples Hosp Wuhu, Dept Gastrointestinal Surg, Wuhu, Anhui, Peoples R China
[2] Fatima Jinnah Med Univ, Lahore, Pakistan
[3] Sharif Med & Dent Coll, Lahore, Pakistan
[4] King Saud Univ, Dept Biochem, Riyadh, Saudi Arabia
[5] King Saud Univ, Coll Food & Agr Sci, Dept Food Sci & Nutr, Riyadh, Saudi Arabia
[6] Al Farahidi Univ, Coll Med Tech, Baghdad, Iraq
[7] Al Turath Univ Coll, Baghdad, Iraq
[8] Univ Vienna, Dept Pharmaceut Sci, Div Pharmacol & Toxicol, Vienna, Austria
[9] King Saud Univ, Coll Sci, Dept Bot & Microbiol, PO 2455, Riyadh 11451, Saudi Arabia
[10] King Saud Univ, Coll Sci, Dept Bot & Microbiol, PO 2455, Riyadh 11451, Saudi Arabia
来源
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH | 2023年 / 15卷 / 03期
关键词
Lung adenocarcinoma; hub genes; biomarkers; chemotherapeutic drugs; EXPRESSION OMNIBUS; PROGNOSTIC-FACTORS; TISSUE INHIBITOR; BREAST-CANCER; SERUM-LEVELS; TUMOR; TIMP1; INTERLEUKIN-6; OSTEOPONTIN; CLASSIFICATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Lung adenocarcinoma (LUAD) is recognized as one of the most prevalent and deadliest malignancies around the globe. The molecular mechanisms behind LUAD have not been fully elucidated. This study was launched to explore LUAD-associated hub genes and their enriched pathways using bioinformatics methods. Methods: Information on GSE10072 was retrieved from the Gene Expression Omnibus (GEO) database and analyzed via the Limma package-based GEO2R tool to obtain the top 100 differentially expressed genes (DEGs) in LUAD. The protein-protein interaction (PPI) network of the DEGs was drawn using the STRING website and was shifted into Cytoscape to screen the top 6 hub genes via the CytoHubba application. Furthermore, the expression analysis and validation of hub genes in LUAD samples and cell lines were done using UALCAN, OncoDB, and GENT2 databases. Moreover, OncoDB was also used for analyzing hub gene DNA methylation levels. In addition, cBioPortal, GSEA tool, Kaplan-Meier (KM) plotter, Enrichr, CancerSEA, and DGIdb were performed to explore some other important aspects of hub genes in LUAD. Results: We identified Interleukin 6 (IL6), Collagen, type I, alpha 1 (COL1A1), TIMP metallopeptidase inhibitor 1 (TIMP1), CD34 molecule (CD34), Decorin (DCN), and Secreted Phosphoprotein 1 (SPP1) genes as the hub genes in LUAD, out of which IL6, CD34, and DCN were significantly down-regulated while COL1A1, TIMP1, and SPP1 were significantly up-regulated in LUAD cell lines and samples of diverse clinical variables. In this study, we also documented some important correlations between hub genes and other parameters such as DNA methylation, genetic alterations, Overall Survival (OS), and 14 important states at the single cell level. Lastly, we also identified hub genes associated with the ceRNA network and 11 important chemotherapeutic drugs. Conclusion: We identified 6 hub genes involved in the development and progression of LUAD. These hub genes can also be helpful in the accurate detection of LUAD and provide novel ideas for treatment.
引用
收藏
页码:1550 / 1568
页数:19
相关论文
共 65 条
  • [51] Clinical utility of measuring expression levels of KAP1, TIMP1 and STC2 in peripheral blood of patients with gastric cancer
    Wang, Yuan-Yu
    Li, Li
    Zhao, Zhong-Sheng
    Wang, Hui-Ju
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2013, 11
  • [52] Wang Z, EBIOMEDICINE
  • [53] The incredible shrinking world of DNA microarrays
    Wheelan, Sarah J.
    Murillo, Francisco Martinez
    Boeke, Jef D.
    [J]. MOLECULAR BIOSYSTEMS, 2008, 4 (07) : 726 - 732
  • [54] Identification of a Four-Gene Signature Associated with the Prognosis Prediction of Lung Adenocarcinoma Based on Integrated Bioinformatics Analysis
    Wu, Yuan
    Yang, Lingge
    Zhang, Long
    Zheng, Xinjie
    Xu, Huan
    Wang, Kai
    Weng, Xianwu
    [J]. GENES, 2022, 13 (02)
  • [55] TIMP-1 as a tumor marker in breast cancer -: An update
    Wuertz, Sidse O.
    Schrohl, Anne-Sofie
    Mouridsen, Henning
    Bruenner, Nils
    [J]. ACTA ONCOLOGICA, 2008, 47 (04) : 580 - 590
  • [56] Plasma and serum levels of tissue inhibitor of metalloproteinases-1 are associated with prognosis in node-negative breast cancer
    Wurtz, Sidse Ornbjerg
    Moller, Susanne
    Mouridsen, Henning
    Hertel, Pernille Braemer
    Friis, Esbern
    Brunner, Nils
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (02) : 424 - 430
  • [57] High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma
    Xie, Tian
    Li, Xingyu
    Ye, Fei
    Lu, Chenxi
    Huang, Haitao
    Wang, Fei
    Cao, Xiaolei
    Zhong, Chongjun
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (01) : 65 - 72
  • [58] Identification of Hub Genes of Lung Adenocarcinoma Based on Weighted Gene Co-Expression Network in Chinese Population
    Xie, Yuning
    Wu, Hongjiao
    Hu, Wenqian
    Zhang, Hongmei
    Li, Ang
    Zhang, Zhi
    Ren, Shuhua
    Zhang, Xuemei
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [59] Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
    Yoshida, N
    Ikemoto, S
    Narita, K
    Sugimura, K
    Wada, S
    Yasumoto, R
    Kishimoto, T
    Nakatani, T
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (09) : 1396 - 1400
  • [60] CancerSEA: a cancer single-cell state atlas
    Yuan, Huating
    Yan, Min
    Zhang, Guanxiong
    Liu, Wei
    Deng, Chunyu
    Liao, Gaoming
    Xu, Liwen
    Luo, Tao
    Yan, Haoteng
    Long, Zhilin
    Shi, Aiai
    Zhao, Tingting
    Xiao, Yun
    Li, Xia
    [J]. NUCLEIC ACIDS RESEARCH, 2019, 47 (D1) : D900 - D908